BDX (Becton Dickinson) Total Liabilities : $31,397 Mil (As of Sep. 2024)

View and export this data going back to 1963. Start your Free Trial

What is Becton Dickinson Total Liabilities?

Becton Dickinson's Total Liabilities for the quarter that ended in Sep. 2024 was $31,397 Mil.

Becton Dickinson's quarterly Total Liabilities increased from Mar. 2024 ($28,509.00 Mil) to Jun. 2024 ($29,713.00 Mil) and increased from Jun. 2024 ($29,713.00 Mil) to Sep. 2024 ($31,397.00 Mil).

Becton Dickinson's annual Total Liabilities declined from Sep. 2022 ($27,652.00 Mil) to Sep. 2023 ($26,983.00 Mil) but then increased from Sep. 2023 ($26,983.00 Mil) to Sep. 2024 ($31,397.00 Mil).

Becton Dickinson Total Liabilities Historical Data

The historical data trend for Becton Dickinson's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson Total Liabilities Chart

Becton Dickinson Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Total Liabilities

Get a 7-Day Free Trial

30,247.00

30,203.00

27,652.00

26,983.00

31,397.00

Becton Dickinson Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															26,983.00	26,941.00	28,509.00	29,713.00	31,397.00

Becton Dickinson Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Becton Dickinson's Total Liabilities for the fiscal year that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8956	+	(17940	+	3559
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	942)
	=	31,397

Total Liabilities	=	Total Assets (A: Sep. 2024 )	-	Total Equity (A: Sep. 2024 )
	=	57286	-	25889
	=	31,397

Becton Dickinson's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8956	+	(17940	+	3559
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	942)
	=	31,397

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	57286	-	25889
	=	31,397

Becton Dickinson Total Liabilities Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Becton Dickinson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (NYSE:BDX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BDX:Mexico 1BDX:Italy 0R19:UK BOX:Germany BOX:Germany BOX:Germany BDX:Austria

Address

1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880

Website

https://www.bd.com

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

Executives

Thomas J Spoerel	officer: VP Controller & Chief Acct Off	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Roland Goette	officer: EVP and President, EMEA	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Michael David Garrison	officer: EVP and President Medical	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Richard Byrd	officer: EVP & President Interventional	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Claire Fraser	director	C/O BECTON, DICKINSON AND COMPANY, FRANKLIN LAKES NJ 07465
David Hickey	officer: EVP & President, Life Sciences	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Joanne Waldstreicher	director	C/O STRUCTURE THERAPEUTICS INC., 611 GATEWAY BLVD, SUITE 223, SOUTH SAN FRANCISCO CA 94080
Michelle Quinn	officer: EVP and Acting General Counsel	1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Shan	officer: EVP, Integrated Supply Chain	1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher Delorefice	officer: EVP & CFO	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Polen Thomas E Jr	officer: Executive Vice President	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Samrat S. Khichi	officer: EVP and General Counsel	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Rishi Grover	officer: EVP and Chief ISC Officer	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Pavan Kumar Mocherla	officer: EVP and President Greater Asia	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
James C Lim	officer: Executive Vice President	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417